Figure 5. Signatures of CH mutations.
(A) Overall mutational signature of CH mutations. (B) Proportion of mutations attributed to signatures, which were assigned previously by Alexandrov et. al (23). Signature 3 and Signature 4 contributed most to the total mutational signature. (C) Rates of nucleotide substitution of Signature 3 and Signature 4. Data came from Alexandrov et. al (23). (D) Lung cancer patients had lower proportion of Signature 3. (E) Smoker had higher fraction of Signature 4.